Peer-influenced content. Sources you trust. No registration required. This is HCN.

Healthline3-Month Intermittent Fasting Program Led to Significant Weight Loss

This randomized controlled trial (n=99) demonstrates that a 3-month time-restricted eating intervention with 8-hour feeding windows produces sustained weight loss at 12-month follow-up. The study provides valuable long-term data on TRE effectiveness, showing 85-88% adherence rates and maintained weight reduction across different timing protocols.


⚕️ Key Clinical Considerations ⚕️

  • Evidence Quality: Well-designed RCT with 12-month follow-up, though results not yet peer-reviewed and sample size relatively modest for definitive clinical recommendations.
  • Weight Loss Efficacy: TRE groups achieved 3.5-4.5% body weight reduction (≈8 pounds) versus 1.5% in controls, with sustained 0.7-2% weight loss at one year.
  • Timing Flexibility: Early TRE (before 10am), late TRE (after 1pm), and self-selected windows showed comparable effectiveness, supporting individualized approaches.
  • Adherence Advantage: High compliance rates (85-88%) attributed to simplified approach requiring no calorie counting or food restriction, only meal timing modification.
  • Safety Considerations: Potential contraindications include age >75, pregnancy, diabetes requiring medication adjustment, and cardiovascular disease given conflicting 2024 AHA data.

🎯 Clinical Practice Impact 🎯

  • Patient Communication: Present TRE as evidence-based option for weight management with flexibility in timing implementation. Emphasize that benefits appear independent of specific eating window, allowing personalization based on lifestyle and work schedules.
  • Practice Integration: Consider TRE for motivated patients struggling with traditional calorie-counting approaches. Implement gradual transition protocols and establish clear monitoring parameters for metabolic health markers during initial weeks.
  • Risk Management: Screen thoroughly for contraindications including advanced age, pregnancy, diabetes requiring precise meal timing, and cardiovascular disease. Monitor for side effects including fatigue, headaches, and potential medication timing conflicts.
  • Action Items: Develop patient education materials explaining TRE protocols, establish follow-up schedules for weight and metabolic monitoring, and create referral pathways for nutritional counseling when combining with Mediterranean diet principles.

More on Fasting

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form